首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cell reports medicine

缩写:

ISSN:2666-3791

e-ISSN:2666-3791

IF/分区:10.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1770
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
James R Lindsay,Jennifer Altreuter,Joao V Alessi et al. James R Lindsay et al.
Deciphering the composition and spatial organization of the tumor immune microenvironment (TIME) is key to understanding cancer progression and treatment response. Spatial biology techniques such as multiplex immunofluorescence (mIF) offer ...
Georgia Clayton,Elisa C Toffoli,Tanja D de Gruijl et al. Georgia Clayton et al.
Dendritic cells (DCs) are potent antigen-presenting cells, key for inducing anti-tumoral immune responses in the tumor microenvironment (TME) and tumor-draining lymph nodes. Within the TME, immunosuppressive signals often render DCs dysfunc...
Remy M Muts,Astrid Hendriks,Josefien W Hommes et al. Remy M Muts et al.
Therapeutic antibodies are actively explored as alternative to treat or prevent bacterial infections. However, the narrow antigen specificity of IgG in combination with broad diversity in bacterial surface structures currently hampers the d...
Philipp A Lang,Lisa Holnsteiner,Yara M Machlah et al. Philipp A Lang et al.
The non-cytopathic arenavirus lymphocytic choriomeningitis virus (LCMV) induces strong anti-tumor responses. To generate an optimized arenavirus for tumor therapy, we passage LCMV in human or murine tumor cells. Occurring mutations shift th...
Francesca Lodi,Sam Vanmassenhove,Duojiao Chen et al. Francesca Lodi et al.
Pan-cancer single-cell atlases explore the heterogeneity of cell types residing within the tumor microenvironment (TME). So far, atlases focused on individual cell types, failing to capture the full complexity of the TME. Here, we present a...
Dun Niu,Xiaozhuang Ma,Junshi Zhu et al. Dun Niu et al.
The clinical translation of combined immunocytokine (IC) and immune checkpoint inhibitor (ICI) is constrained by relapse of advanced malignancies, systemic toxicities, and prohibitive research and synthesis costs. In this study, the circCV-...
Melissa M Lane,Amelia J McGuinness,Mohammadreza Mohebbi et al. Melissa M Lane et al.
In a single-blind, two-arm, randomized controlled-feeding trial (May 2021-February 2022), 47 women (30-65 years, BMI 30-45 kg/m2) are randomized to either a food-based or a supplement-based very-low-energy diet (VLED: 800-900 kcal/d) for 3 ...
Griffin I Kane,Tiana E Naylor,Ellis F Lusi et al. Griffin I Kane et al.
We report on the utility of a "super-adjuvant" nanoparticle (NP) system as a modular, customizable platform for next-generation cancer vaccination. Using nanomaterials engineering technology, we aim to harness not only the effective adjuvan...
Chen Yang,Ping Wang,Mingjun Yang et al. Chen Yang et al.
The poor prognosis of patients with recurrent or refractory T cell malignancies emphasizes the need for improved immunotherapies. CD5 is a characteristic marker of malignant T cells and is expressed on almost all normal T cells. Therefore, ...
Jun-Yao Xu,Huan Chen,Yao-Yu Yu et al. Jun-Yao Xu et al.
Gut microbiota has been reported to be associated with the development of various diseases; however, its interaction with clear cell renal cell carcinoma (ccRCC) remains unknown. To investigate the potential relationship between gut microbi...